| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer
|
Tu, Hai-Yan
|
|
2017
|
114 |
C |
p. 96-102
|
artikel
|
| 2 |
Cardiogenic shock in a patient being treated with atezolizumab for metastatic non-small cell lung cancer
|
Liu, Ellen
|
|
2017
|
114 |
C |
p. 106-107
|
artikel
|
| 3 |
Changing costs of metastatic non small cell lung cancer in the Netherlands
|
Keusters, W.R.
|
|
2017
|
114 |
C |
p. 56-61
|
artikel
|
| 4 |
Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy
|
Shen, Jie
|
|
2017
|
114 |
C |
p. 70-78
|
artikel
|
| 5 |
Clinical characteristics and sequence complexity of anaplastic lymphoma kinase gene fusions in Chinese lung cancer patients
|
Tian, Hong-xia
|
|
2017
|
114 |
C |
p. 90-95
|
artikel
|
| 6 |
Clinical outcomes of black vs. non-black patients with locally advanced non–small cell lung cancer
|
Vyfhuis, Melissa A.L.
|
|
2017
|
114 |
C |
p. 44-49
|
artikel
|
| 7 |
Contents
|
|
|
2017
|
114 |
C |
p. iv-v
|
artikel
|
| 8 |
C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients
|
Yamauchi, Yoshikane
|
|
2017
|
114 |
C |
p. 62-67
|
artikel
|
| 9 |
De novo ERBB2 amplification causing intrinsic resistance to erlotinib in EGFR-L858R mutated TKI-naïve lung adenocarcinoma
|
Carney, Brian J.
|
|
2017
|
114 |
C |
p. 108-110
|
artikel
|
| 10 |
Durable response to osimertinib in EGFR mutated T790M wildtype non-small cell lung cancer with leptomeningeal metastases: A case report
|
Chalmers, Anna
|
|
2017
|
114 |
C |
p. 68-69
|
artikel
|
| 11 |
Early detection of lung cancer using ultra-low-dose computed tomography in coronary CT angiography scans among patients with suspected coronary heart disease
|
Zanon, Matheus
|
|
2017
|
114 |
C |
p. 1-5
|
artikel
|
| 12 |
Editorial Board
|
|
|
2017
|
114 |
C |
p. iii
|
artikel
|
| 13 |
Esophageal ultrasound (EUS) assessment of T4 status in NSCLC patients
|
Kuijvenhoven, Jolanda C.
|
|
2017
|
114 |
C |
p. 50-55
|
artikel
|
| 14 |
Genetic predisposition to lung adenocarcinoma among never-smoking Chinese with different epidermal growth factor receptor mutation status
|
Han, Li
|
|
2017
|
114 |
C |
p. 79-89
|
artikel
|
| 15 |
Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p
|
Zhu, Ying
|
|
2017
|
114 |
C |
p. 6-11
|
artikel
|
| 16 |
Matched-pair analysis of a multi-institutional cohort reveals that epidermal growth factor receptor mutation is not a risk factor for postoperative recurrence of lung adenocarcinoma
|
Matsumura, Yuki
|
|
2017
|
114 |
C |
p. 23-30
|
artikel
|
| 17 |
Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma
|
Sobhani, N.
|
|
2017
|
114 |
C |
p. 103-105
|
artikel
|
| 18 |
Quantification of plasma EGFR mutations in patients with lung cancers: Comparison of the performance of ARMS-Plus and droplet digital PCR
|
Wang, Lin
|
|
2017
|
114 |
C |
p. 31-37
|
artikel
|
| 19 |
Targeting DNA damage in SCLC
|
Foy, Victoria
|
|
2017
|
114 |
C |
p. 12-22
|
artikel
|
| 20 |
Treatment of a NSCLC patient with osimertinib based on the detection of the EGFR T790M resistance mutation in cerebrospinal fluid
|
Théoleyre, Sandrine
|
|
2017
|
114 |
C |
p. 111-112
|
artikel
|
| 21 |
Vasculature surrounding a nodule: A novel lung cancer biomarker
|
Wang, Xiaohua
|
|
2017
|
114 |
C |
p. 38-43
|
artikel
|
Tijdschrift beschrijving